| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |